Fresenius Medical Care (FMS) Stock Price, News & Analysis

Company Overview

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Key Stats

• Today's Range: $22.45 to $22.89
• 50-Day Range: $19.11 to $24.18
• 52-Week Range: $17.93 to $24.31
• Volume: 407,799 shs
• Average Volume: 357,488 shs
• Market Capitalization: $13.39 billion
• P/E Ratio: 18.85
• Dividend Yield: 1.93%
• Price Target: $24.30
• Consensus Rating: Hold

Fresenius Medical Care Stock Analysis - MarketRank™

Fresenius Medical Care scored higher than 70% of companies evaluated by MarketBeat, and ranked 315th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Fresenius Medical Care has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Fresenius Medical Care has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 4.4 / 5
• Proj. Earnings Growth: 25.16%

Earnings Growth

Earnings for Fresenius Medical Care are expected to grow by 25.16% in the coming year, from $1.55 to $1.94 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Fresenius Medical Care is 18.85, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.45.

Price to Earnings Ratio vs. Sector

The P/E ratio of Fresenius Medical Care is 18.85, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 89.58.

Price to Earnings Growth Ratio

Fresenius Medical Care has a PEG Ratio of 0.96. PEG Ratios around 1 indicate that a company is correctly valued.

Price to Book Value per Share Ratio

Fresenius Medical Care has a P/B Ratio of 0.83. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.15% of the outstanding shares of Fresenius Medical Care have been sold short.

Short Interest Ratio / Days to Cover

Fresenius Medical Care has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Fresenius Medical Care has recently decreased by 6.41%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Fresenius Medical Care pays a meaningful dividend of 1.87%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Fresenius Medical Care does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Fresenius Medical Care is 36.36%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Fresenius Medical Care will have a dividend payout ratio of 22.68% next year. This indicates that Fresenius Medical Care will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.15% of the outstanding shares of Fresenius Medical Care have been sold short.

Short Interest Ratio / Days to Cover

Fresenius Medical Care has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Fresenius Medical Care has recently decreased by 6.41%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 1.06

News Sentiment

Fresenius Medical Care has a news sentiment score of 1.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Fresenius Medical Care this week, compared to 2 articles on an average week.

MarketBeat Follows

Only 2 people have added Fresenius Medical Care to their MarketBeat watchlist in the last 30 days. This is a decrease of -89% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Fresenius Medical Care insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 8.37% of the stock of Fresenius Medical Care is held by institutions.

FMS Stock Analysis - Frequently Asked Questions

How have FMS shares performed this year?

Fresenius Medical Care's stock was trading at $20.83 at the beginning of 2024. Since then, FMS stock has increased by 9.5% and is now trading at $22.81.
View the best growth stocks for 2024 here.

How were Fresenius Medical Care's earnings last quarter?

Fresenius Medical Care AG (NYSE:FMS) released its quarterly earnings data on Wednesday, November, 1st. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.37 by $0.06. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.42 billion. Fresenius Medical Care had a net margin of 3.43% and a trailing twelve-month return on equity of 6.04%.

Does Fresenius Medical Care have any subsidiaries?

The following companies are subsidiaries of Fresenius Medical Care: NxStage Medical.

Who are Fresenius Medical Care's major shareholders?

Top institutional shareholders of Fresenius Medical Care include Pzena Investment Management LLC (2.76%), Moran Wealth Management LLC (0.04%), Quantinno Capital Management LP (0.02%) and Geode Capital Management LLC (0.02%).

How do I buy shares of Fresenius Medical Care?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Fresenius Medical Care own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Energy Transfer (ET), AbbVie (ABBV), General Electric (GE) and Adobe (ADBE).

Company Calendar

• Last Earnings: 11/01/2023
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Miscellaneous health & allied services, not elsewhere classified
• Sub-Industry: Healthcare
• Current Symbol: NYSE:FMS
• CUSIP: N/A
• CIK: 1333141
• Web: www.freseniusmedicalcare.com
• Phone: (496) 172-6090
• Fax: 49-6172-609-2301
• Employees: 1,358
• Year Founded: 1912

Price Target and Rating

• Average Stock Price Target: $24.30
• High Stock Price Target: $25.60
• Low Stock Price Target: $23.00
• Potential Upside/Downside: +6.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $1.21
• Trailing P/E Ratio: 18.85
• Forward P/E Ratio: 14.72
• P/E Growth: 0.96
• Net Income: $540.07 million
• Net Margins: 3.43%
• Pretax Margin: 6.35%
• Return on Equity: 6.04%
• Return on Assets: 2.69%

Debt

• Debt-to-Equity Ratio: 0.42
• Current Ratio: 1.37
• Quick Ratio: 1.02

Sales & Book Value

• Annual Sales: $19.24 billion
• Price / Sales: 0.70
• Cash Flow: $4.42 per share
• Price / Cash Flow: 5.16
• Book Value: $27.34 per share
• Price / Book: 0.83

Miscellaneous

• Outstanding Shares: 586,827,000
• Free Float: N/A
• Market Cap: $13.39 billion
• Optionable: Optionable
• Beta: 0.94